Herbalife Ltd.
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K/A
Amendment No. 1
FOR
ANNUAL AND TRANSITION REPORTS
PURSUANT TO SECTIONS 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
December 31, 2007
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file
number: 1-32381
HERBALIFE
LTD.
(Exact Name of Registrant as
Specified in Its Charter)
|
|
|
Cayman Islands
|
|
98-0377871
|
(State or Other Jurisdiction
of
|
|
(I.R.S. Employer
|
Incorporation or
Organization)
|
|
Identification
No.)
|
|
|
|
P.O. Box 309GT
|
|
90067
|
Ugland House, South Church Street
Grand Cayman, Cayman Islands
(Address of Principal
Executive Offices)
|
|
(Zip Code)
|
(310) 410-9600
(Registrants telephone
number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
Common Shares, par value $0.002 per share
|
|
|
New York Stock Exchange
|
|
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes þ No o
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229,405 of this chapter) is not contained herein,
and will not be contained, to the best of registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
|
Non-accelerated
filer o
(Do not check if a smaller reporting company)
|
|
Smaller Reporting
company o
|
Indicate by check mark whether registrant is a shell company (as
defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
There were 65,114,740 common shares outstanding as of
April 28, 2008. The aggregate market value of the
Registrants common shares held by non-affiliates was
approximately $2,542 million as of June 29, 2007,
based upon the last reported sales price on the New York
Stock Exchange on that date of $39.65.
DOCUMENTS
INCORPORATED BY REFERENCE
None.
EXPLANATORY
NOTE
We are filing this Amendment No. 1 (this
Amendment) to our Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, which was
originally filed with the Securities and Exchange Commission
(the SEC) on February 26, 2008 (the
Original
Form 10-K)
to correct certain errant biographical information with respect
to Gregory Probert, our former President and Chief Operating
Officer, which, as previously disclosed in our Current Report on
Form 8-K
filed with the SEC on April 25, 2008, was only recently
brought to the Companys attention.
Part I, Item 1 and Part III, Item 10 of the
Original
Form 10-K
are hereby amended and restated in their entirety as set forth
in this Amendment to correct the errant biographical information
with respect to Mr. Probert. In connection with the filing
of this Amendment and pursuant to SEC
rule 12b-15,
we are filing as exhibits to this Amendment new certifications
of our principal executive officer and principal financial
officer under Part IV, Item 15 hereof.
Other than those changes outlined above, there are no changes to
the Original
Form 10-K.
This Amendment does not change our previously reported financial
statements or the other disclosures contained in the Original
Form 10-K.
This Amendment does not reflect events occurring after the
filing of the Original
Form 10-K,
nor does it modify or update disclosures therein in any way
other than as required to reflect the amendments described
above. Among other things, forward-looking statements made in
the Original
Form 10-K
have not been revised to reflect events that occurred or facts
that became known to us after the filing of the Original
Form 10-K,
and such forward looking statements should be read in their
historical context.
2
PART I
GENERAL
We are a global network marketing company that sells weight
management, nutritional supplement, energy & fitness
products and personal care products. We pursue our mission of
changing peoples lives by providing a
financially rewarding business opportunity to distributors and
quality products to distributors and customers who seek a
healthy lifestyle. We are one of the largest network marketing
companies in the world with net sales of approximately
$2.1 billion for the fiscal year ended December 31,
2007. We sell our products in 65 countries through a network of
over 1.7 million independent distributors. In China, in
order to comply with local laws and regulations, we sell our
products through retail stores and an employed sales force. We
believe the quality of our products and the effectiveness of our
distribution network, coupled with geographic expansion, have
been the primary reasons for our success throughout our
28-year
operating history.
We offer science based products in four principal categories:
weight management, targeted nutrition, energy &
fitness and Outer Nutrition. The weight management product
portfolio includes meal replacement shakes, weight-loss
enhancers, appetite suppressors and a variety of healthy snacks.
Our collection of targeted nutrition products includes dietary
supplements which contain quality herbs, vitamins, minerals and
natural ingredients that support total well-being and long-term
good health. The energy & fitness category includes
energy and isotonic drinks to support a healthy active
lifestyle. Our Outer Nutrition products include skin cleansers,
moisturizers and lotions with antioxidants, as well as
anti-aging products. Weight management, targeted nutrition,
energy & fitness and Outer Nutrition accounted for
63.4%, 20.2%, 4.2% and 6.7% of our net sales in fiscal year
2007, respectively.
We believe that the direct-selling channel is ideally suited to
marketing our products, because sales of weight management,
nutrition and personal care products are strengthened by ongoing
personal contact between retail consumers and distributors. This
personal contact may enhance consumers nutritional and
health education as well as motivate consumers to begin and
maintain wellness and weight management programs. In addition,
many of our distributors use our products themselves, and can
therefore provide first-hand testimonials of product
effectiveness to consumers, which often serve as a powerful
sales tool.
We are focused on building and maintaining our distributor
network by offering financially rewarding and flexible career
opportunities through sales of quality, innovative and
efficacious products to health conscious consumers. We believe
the income opportunity provided by our network marketing program
appeals to a broad cross-section of people throughout the world,
particularly those seeking to supplement family income, start a
home business or pursue entrepreneurial, full and part-time,
employment opportunities. Our distributors, who are independent
contractors, can profit from selling our products and can also
earn royalties and bonuses on sales made by the other
distributors whom they recruit to join their sales organizations.
We enable distributors to maximize their potential by providing
a broad array of motivational, educational and support services.
We motivate our distributors through our performance-based
compensation plan, individual recognition, reward programs and
promotions, and participation in local, national and
international Company-sponsored sales events such as
Extravaganzas. We are committed to providing professionally
designed educational training materials that our distributors
can use to enhance recruitment and maximize their sales. We and
our distributor leadership conduct thousands of training
sessions each year throughout the world to educate and motivate
our distributors. These training events teach our distributors
not only how to develop invaluable business-building and
leadership skills, but also how to differentiate our products to
consumers. Our corporate-sponsored training events provide a
forum for distributors, who otherwise operate independently, to
share ideas with us and each other. In addition, we operate an
internet-based Herbalife Broadcasting Network, which delivers
worldwide, educational, motivational and inspirational content,
including addresses from our Chief Executive Officer, to our
distributors. Our efficient and effective distribution,
logistics and customer care support system assists our
distributors by providing same day, or
next-day
sales capabilities and support services. We further aid our
distributors by generating additional demand for our products
through traditional marketing and public relations activities,
such as television ads, sporting event sponsorships and
endorsements.
3
Our
Competitive Strengths
We believe that our success stems from our ability to motivate
our distributor network with a range of quality, innovative and
efficacious products that appeal to consumer preferences for
healthy living. We have been able to achieve sustained and
profitable growth by capitalizing on the following competitive
strengths:
Distributor
Base
As of December 2007, we had over 1.7 million distributors,
which includes approximately 129,000 China sales representatives
and employees. Collectively we refer to this group as
distributors. Approximately 473,000 of our
1.7 million distributors have become sales leaders, which
are comprised of approximately 451,000 supervisors in the 64
countries where we use our traditional marketing plan and 22,000
China sales employees operating under our China marketing plan.
Collectively we refer to this group as sales
leaders. We believe that the distributors who have not
attained supervisor level can be segmented into three general
categories based on their product order patterns: discount
buyers, small retailers and potential supervisors. We define
discount buyers as customers who have signed up as distributors
to enjoy a discount on their purchases; small retailers as
product users and sales people who generate modest sales to
friends and family; and potential supervisors as distributors
who are proactively developing a business with the intention of
qualifying to become a supervisor. In 2007, excluding China,
distributor orders for these three general categories were
approximately 52%, 26% and 22%, respectively. For the
approximately 451,000 supervisors in our organization, the
marketing plan encourages active participation in the business
including building down-line sales organizations of their own,
which can serve to increase their income and increase our
product sales. Sales leaders contribute significantly to our
sales.
Product
Portfolio
We are committed to building distributor, customer and brand
loyalty by providing a diverse portfolio of health-oriented and
wellness products. The breadth of our product offerings enables
our distributors to sell a comprehensive package of products
designed to simplify weight management and nutrition. Many of
our product formulations have been in existence for years;
however, we continually review, and if necessary, improve our
product formulations, based upon developments in nutrition
science. We believe that the longevity and variety in our
product portfolio significantly enhance our distributors
abilities to build their businesses.
Nutrition
Science-Based Product Development
We continue to emphasize and make investments in science-based
product development in the fields of weight management,
nutrition and personal care. We have a growing internal team of
scientists dedicated to continually evaluating opportunities to
enhance our existing products and to develop new science-based
products. These product development efforts are reviewed by
prominent doctors and world-renowned scientists who constitute
our Scientific Advisory Board and Nutrition Advisory Board. In
addition, we have provided donations to assist in the
establishment of the Mark Hughes Cellular and Molecular Lab at
UCLA, or the UCLA Lab, and we continue to rely on their
expertise. We believe that the UCLA Lab provides opportunities
for Herbalife to access cutting-edge science in herbal research
and nutrition. In 2007, Herbalife awarded a research grant to
the National Center for Natural Products Research at the
University of Mississippi School of Pharmacy, or NCNPR. The
grant will allow NCNPR scientists to identify and study the
biologically active chemicals found in botanicals, which may be
used in the development of future dietary supplements and skin
care products for Herbalife.
Scalable
Business Model
Our business model enables us to grow our business with only
moderate investment in our infrastructure and other fixed costs.
With the exception of our China business, we require no
Company-employed sales force to market and sell our products. We
incur no direct incremental cost to add a new distributor in our
existing markets, and our distributor compensation varies
directly with sales. In addition, our distributors bear the
majority of our consumer marketing expenses, and supervisors
sponsor and coordinate a large share of distributor recruiting
and training initiatives. Furthermore, we can readily increase
production and distribution of our products as a result of our
numerous third party manufacturing relationships as well as our
global footprint of in-house distribution centers.
4
Geographic
Diversification
We have a proven ability to establish our network marketing
organization in new markets. Since our founding 28 years
ago, we have expanded our presence into 65 countries. While
sales within our local markets may fluctuate due to economic,
market and regulatory conditions, competitive pressures,
political and social instability or for Company-specific
reasons, we believe that our geographic diversity mitigates our
financial exposure to any particular market.
Experienced
Management Team
Our management team is led by Michael O. Johnson who became our
Chief Executive Officer after spending 17 years with The
Walt Disney Company, where he most recently served as President
of Walt Disney International. In 2007, he was named Chairman.
Since joining our Company, Mr. Johnson has assembled a team
of experienced executives, including Gregory Probert, President
and Chief Operating Officer and formerly Chief Executive Officer
of DMX Music and Chief Operating Officer of The Walt Disney
Companys Buena Vista Home Entertainment division; Richard
Goudis, Chief Financial Officer and formerly Chief Operating
Officer of Rexall Sundown; Brett R. Chapman, General
Counsel and formerly Senior Vice President and Deputy General
Counsel of The Walt Disney Company; and Steve Henig, Ph.D.,
Chief Scientific Officer with responsibility for our product
research and development, and formerly Senior Vice President of
Ocean Spray Cranberries, Inc.
Our
Business Strategy
We believe that our network marketing model is the most
effective way to sell our products. Our objective is to increase
the recruitment, retention, retailing and productivity of our
distributor base by pursuing the following strategic initiatives:
Major
Market Strategy
We look to optimize country operating models, further aligning
resources to fuel growth in high potential markets, develop
lower-cost models where appropriate and centralize key regional
functions. Expanding in China represents a significant growth
opportunity for us as we believe that China could become one of
the largest direct-selling markets in the world over the next
several years. To address this opportunity, we have assembled a
management team with direct selling experience, secured a
headquarters location in Shanghai, expanded our manufacturing
capacity in our Suzhou, China factory and in July 2007, received
a direct-selling license for the Jiangsu province. We are in the
process of opening retail locations and pursuing direct-selling
licenses in additional provinces. Through December 2007, we have
opened 90 retail stores in 29 provinces. Other critical major
market strategies include developing an Eastern European
strategy, nurturing Brazils transition to a better balance
of retailing, retention and recruiting, and identifying new
untapped markets.
Product
Strategy
We are committed to providing our distributors with unique,
innovative products to help them increase sales and recruit new
distributors. Product development is focused on obesity,
anti-aging, fitness, childrens health, and immunity
enhancers. On an ongoing basis we will augment our product
portfolio with additional science-based products and, as
appropriate, will bundle products addressing similar health
concerns into packages and programs. We are establishing a core
set of products that will be available in all markets around the
world. We are also empowering regional and country managers to
develop unique products that are specific to their markets to
ensure that local consumer needs can be met. Additionally, each
year we plan to have mega launches of products
and/or
programs to generate continual excitement among our
distributors, to add to our core set of products and to support
our distributor DMOs. These mega launches will
generally target specific market segments deemed strategic to
us, such as the 2007 introduction of a childrens line to
target
stay-at-home
moms and a sports and fitness line to target consumers with
active lifestyles.
5
Distributor
Strategy
We continue to increase our investment in events and promotions
as a catalyst to help our distributors improve the effectiveness
and productivity of their businesses. We will attempt to
globalize best-practice business methods to enable our
distributors to improve their penetration in existing markets.
We refer to these business methods as DMOs and they include
Nutrition Clubs, the Total Plan, Wellness Coach and
Internet/Sampling. We also introduced BizWorks, a business
system which assists our distributors in building their
businesses more efficiently while better servicing their
existing customers. And finally, to increase brand awareness
among potential customers and distributors, we have entered into
marketing alliances, created Team Herbalife and
rolled-out a style guide and brand asset library so that our
distributors have access to the Herbalife brand logo for use in
their marketing efforts.
Infrastructure
Strategy
In 2003, we embarked upon a strategic initiative to
significantly upgrade our technology infrastructure throughout
the world. We are implementing an Oracle enterprise-wide
technology solution, with a scalable and stable open
architecture platform, to enhance our efficiency and
productivity as well as that of our distributors. In addition,
we are upgrading our internet-based marketing and distributor
services platform with tools such as BizWorks and
MyHerbalife.com and we have invested in business intelligence
tools to enable better analysis of our business. In 2008, we
expect to execute the next stage of stabilization upgrades for
the software application tier of the Oracle platform with
implementation thereof across multiple regions in 2008 and 2009.
Additionally, we continue to invest in our employees through a
comprehensive and global organizational development program.
Product
Overview
For 28 years, our products have been designed to help
distributors and customers from around the world lose weight,
improve their health and experience life-changing results. We
have built our heritage on developing formulas that blend the
best of nature with innovative techniques from nutrition
science, appealing to the growing base of consumers seeking
differentiated products and desiring a healthier lifestyle.
As of December 31, 2007, we marketed and sold 131 products
encompassing over 3,500 SKUs through our distributors and had
approximately 1,803 trademarks worldwide. We group our products
into four primary categories: weight management, targeted
nutrition, energy & fitness and Outer Nutrition. Our
products are often sold in programs, which are comprised of a
series of related products designed to simplify weight
management and nutrition for our consumers and maximize our
distributors cross-selling opportunities. These programs
target specific consumer market segments, such as women, men or
children, as well as weight-management customers and individuals
looking to enhance their overall well-being.
The following table summarizes our products by product category.
|
|
|
|
|
Product Category
|
|
Description
|
|
Representative Products
|
|
Weight Management
(63.4% of 2007 net sales)
|
|
Meal replacement, weight-loss enhancers and a variety of healthy
snacks
|
|
Formula 1 Healthy Meal, Personalized Protein Powder, Total
Control®,
High Protein Bars and Snacks
|
Targeted Nutrition
(20.2% of 2007 net sales)
|
|
Dietary and nutritional supplements containing quality herbs,
vitamins, minerals and other natural ingredients
|
|
Niteworks®,
Garden
7®
phytonutrient supplement, Best
Defense®
for improved immune system, Kids Line
|
Energy & Fitness
(4.2% of 2007 net sales)
|
|
Products that support a healthy active lifestyle
|
|
Liftoff®
energy drink, H3OTM hydration drink
|
Outer Nutrition
(6.7% of 2007 net sales)
|
|
Skin cleansers, moisturizers, lotions, shampoos and conditioners
|
|
Skin
Activator®
Anti-Aging line,
NouriFusion®
skin care line
|
Literature, Promotional and Other Products
(5.5% of 2007 net sales)
|
|
Sales aids, informational audiotapes, CDs, DVDs and start-up kits
|
|
International Business Packs, BizWorks
|
6
Weight
Management
Weight Management is our largest product category representing
63.4% of our net sales for the year 2007. Formula 1, our
best-selling product, is a healthy meal with soy protein,
essential vitamins, minerals and nutrients that is available in
seven delicious flavors and can help support weight management.
It has been part of our basic weight management program for
28 years and generated approximately 30% of our retail
sales for the year 2007. Personalized Protein Powder is a soy
and whey protein product developed to be added to Formula 1 to
boost protein intake and decrease hunger. Weight-loss enhancers,
including Total
Control®,
address specific challenges associated with dieting, such as
lack of energy, hunger and food craving, fluid retention,
decreased metabolism and digestive challenges, by building
energy, boosting metabolism, curbing appetite and helping to
promote weight loss. Healthy snacks are formulated to provide
between-meal nutrition and satisfaction.
Targeted
Nutrition
We market numerous dietary and nutritional supplements designed
to meet our customers specific nutritional needs. Each of
these supplements contains quality herbs, vitamins, minerals and
other natural ingredients and focuses on specific lifestages of
our customers, including women, men, children and those with
health concerns, including heart health, healthy aging,
digestive health, or immune solutions.
Niteworks®
is a product developed in conjunction with Nobel Laureate in
Medicine, Dr. Louis Ignarro, that supports energy,
circulatory and vascular health and enhances blood flow to the
heart, brain and other vital organs. Garden
7®
is designed to provide the phytonutrient benefits of seven
servings of fruits and vegetables and has anti-oxidant and
health-boosting properties. Best
Defense®
is an effervescent drink that boosts immunity. In 2007, we
introduced a new Kids Line including shakes and improved
multivitamins which provide essential nutrition including
protein, fiber and 100% of key nutrients to meet growing
kids daily needs.
Energy
and Fitness
We have entered into the high growth energy drink category with
the introduction of
Liftoff®,
an innovative, effervescent energy product with B-vitamins,
ginseng, ginger and caffeine to increase energy and improve
mental clarity for better performance throughout the day. In
2007, we launched
H3OTM
Fitness Drink to provide rapid hydration, sustained energy plus
antioxidant protection for people living a healthy, active
lifestyle.
Outer
Nutrition
Our Outer Nutrition products complement our weight-management
and targeted nutrition products and aim to improve the
appearance of the body, skin and hair. These products include
skin cleansers, toners, moisturizers and facial masks, shampoos
and conditioners, body-wash items and a selection of fragrances
for men and women.
NouriFusion®
is a personal care product line that utilizes vitamin A, C and E
to provide benefits to the skin. In 2006, we launched an
extension of our successful Skin
Activator®
product, an advanced cream based glucosamine complex to reduce
the appearance of fine lines and wrinkles, into a full line of
anti-aging products.
Literature,
Promotional and Other Products
We also sell literature and promotional materials, including
sales aids, informational audiotapes, videotapes, CDs and DVDs
designed to support our distributors marketing efforts, as
well as
start-up
kits called International Business Packs for new
distributors. In 2006, we introduced BizWorks, a customizable
retail website for our distributors to enhance the on-line
experience and improve their productivity.
Product
Development
We are committed to providing our distributors with unique,
innovative science-based products to help them increase
recruitment, retention and retailing. We believe this can be
best accomplished in part by introducing new products and by
upgrading, reformulating and repackaging existing product lines.
Our internal team of scientists and product developers
collaborate with the Companys Nutrition Advisory Board and
Scientific Advisory Board to formulate, review and evaluate new
product ideas. Once a particular market opportunity has been
identified, our
7
scientists along with our marketing and sales teams work closely
with distributors to effect a successful development and launch
of the product.
A new product development process was implemented globally to
accelerate the introduction of new products and to improve the
launch of products. Cross-functional teams from Product
Marketing, Product Development, Sciences, Licensing,
Manufacturing and Finance were formed and assigned to major
product initiatives.
The product development process is a stage-gate process based on
best in class practices in our industry. The process
consists of five stages: identification, feasibility assessment,
development, launch and learn. The project teams obtain
approvals from a corporate steering team comprised of key
executives in the Company. The process defines each
departments roles and responsibilities and sets clear
deliverables for each stage. It creates a succinct process from
the beginning of the development cycle to the end.
New product ideas are generated and narrowed down to high
potential ideas that fill our business needs and conform to our
overall strategy. We test the most promising ideas with
distributors and customers using a variety of qualitative and
quantitative tools. This testing is followed by a feasibility
assessment which includes a review of product and package
prototypes, product positioning and messaging, process design,
analysis of manufacturing issues and providing preliminary
financial projections of product sales. The next stage is the
development phase in which we finalize the formula, process,
manufacturing strategy, product positioning, pricing, labeling
and other related matters. The fourth stage is the launch phase
in which we prepare promotional and sales materials, complete
the supply chain plan, create product and financial forecasts,
and complete other final preparations for launch. After the
product is launched, we closely track sales performance and the
lessons learned so we can update and improve the product
development process. In addition, during the past three years,
we have significantly increased our investment in clinical
studies and in our science program to substantiate claims and
efficacy of our products.
We reorganized our technical team in 2007 for greater efficiency
in product development as well as to carry out related product
development strategies both globally and regionally. During
2007, we also added new talents to our technical and scientific
teams and additional resources to the Companys Nutrition
and Scientific Advisory Boards.
The Nutrition Advisory Board is headed by David
Heber, M.D., Ph.D., Professor of Medicine and Public
Health at the UCLA School of Medicine, Director of the UCLA
Center for Human Nutrition and Director of the UCLA Center for
Dietary Supplement Research in Botanicals. The Nutrition
Advisory Board has 20 members from 17 countries. It is comprised
of leading scientists and medical doctors who provide training
on product usage and give health-news updates through Herbalife
literature, the Internet and training events around the world.
Our Scientific Advisory Board is chaired by Dr. Heber and
has 12 members from six countries. Louis Ignarro, Ph.D.,
Distinguished Professor of Pharmacology at the UCLA School of
Medicine and Nobel Laureate in Medicine is also a member of the
Scientific Advisory Board.
We believe that it is important to maintain our relationships
with members of our Nutrition Advisory Board and Scientific
Advisory Board to recognize the time and effort that they expend
on our behalf. Each member of our Nutrition Advisory Board other
than Dr. Heber receives a monthly retainer of up to $5,000,
plus up to $3,000 for every day that they appear at a
non-southern California distributor event and up to $2,000 for
every day that they need to travel to such events. Members of
our Scientific Advisory Board are compensated for their time and
efforts in the following manner: (1) ten members are paid
an annual retainer of $5,000 plus travel expenses,
(2) Dr. Ignarro receives no direct compensation from
us although we do pay a consulting firm, with which
Dr. Ignarro is affiliated, a royalty on sales of
Niteworks®,
certain healthy heart products, and other products
that we may mutually designate in the future that are, in each
case, sold with the aid of Dr. Ignarros consulting,
promotional or endorsement services, with such amounts totaling
$1.4 million, $1.0 million and $1.9 million in
2005, 2006 and 2007, respectively and (3) Dr. Heber
generally, other than a one time option grant in 2005, receives
no direct compensation from us although we do reimburse him for
travel expenses and we do pay to a consulting firm, with which
Dr. Heber is affiliated, a quarterly consulting fee of
$75,000.
In 2007, we completed construction and moved into modern,
state-of-the-art product development laboratories in Torrance,
California, as well as quality control laboratories in Carson,
California. This investment will enable our developers,
scientists and quality control staff to accelerate product
development, launch products faster and provide a more robust
quality control program.
8
Herbalife also made further contributions to the UCLA Lab. We
have continually invested in this lab since 2002 with total
donations of approximately $1.4 million which includes
donations of lab equipment and software. UCLA agreed that the
donations would be used for further research and education in
the fields of weight management and botanical dietary
supplements. In addition, we have made donations from time to
time to UCLA to fund research and educational programs. While
our direct relationship with UCLA is currently limited to
conducting one ongoing clinical studies, we intend to take full
advantage of the expertise at UCLA by committing to support
research that will further our understanding of the benefits of
phytochemicals.
In 2007, we introduced new flavors of Formula 1 including
Café Latte and Pina Colada, as well as Protein Bars Deluxe
and Formula 1 in single serve sachets for Weight Management;
Kids Shakes and Kids Multi-Vitamins for Targeted Nutrition;
H3OTM
Fitness Drink for Energy and Fitness and Skin
Activator®
Packettes and Soft Green Line for Outer Nutrition.
We believe our focus on nutrition and botanical science and our
efforts at combining our internal research and development
efforts with the scientific expertise of our Scientific Advisory
Board, the educational skills of the Nutrition Advisory Board
and the resources of the UCLA Lab should result in meaningful
product introductions and give our distributors and consumers
increased confidence in our products.
Network
Marketing Program
General
Our products are distributed through a global network marketing
organization comprised of over 1.7 million independent
distributors in 65 countries, including in China where, due to
regulations, our sales are conducted through Company operated
retail stores, sales representatives and employed sales
management personnel. In China, in the areas where we have a
direct selling license, our distributors and employees can sell
Herbalife product outside the retail establishments. In addition
to helping our distributors achieve physical health and wellness
through use of our products, we offer our distributors, who are
independent contractors, attractive income opportunities.
Distributors may earn income on their own sales and can also
earn royalties and bonuses on sales made by the distributors in
their sales organizations. We believe that our products are
particularly well-suited to the network marketing distribution
channel because sales of weight management and health and
wellness products are strengthened by ongoing personal contact
and coaching between retail consumers and distributors. We
believe our continued commitment to developing innovative,
science-based products will enhance our ability to attract new
distributors as well as increase the productivity and retention
of existing distributors. Furthermore, our international
sponsorship program, which permits distributors to sponsor
distributors in other countries where we are licensed to do
business and where we have obtained required product approvals,
provides a significant advantage to our distributors in
developing and growing their businesses. China has its own
unique marketing program.
On July 18, 2002, we entered into an agreement with our
distributors that no material changes adverse to the
distributors will be made to the existing marketing plan without
their consent and that we will continue to distribute Herbalife
products exclusively through our independent distributors. We
believe that this agreement has strengthened our relationship
with our existing distributors, improved our ability to recruit
new distributors and generally increased the long-term stability
of our business.
Structure
of the Network Marketing Program
To become a distributor in most markets, a person must be
sponsored by an existing distributor and must purchase an
International Business Pack. The International Business Pack is
a distributor kit available in local languages. The product and
literature contents in the kits vary slightly to meet individual
market needs. An example is the large size US IBP, which costs
$87.95 and includes a canister of Formula 1 shake mix, several
bottles of different nutritional supplements, Herbal Concentrate
(Tea),
Liftoff®
(an energy drink), and
Nourifusion®
(skin care) samples, along with a handy tote, booklets
describing us, our compensation plan and rules of conduct,
various training and promotional materials, distributor
applications and a product catalog. The smaller US version costs
$54.95 and includes sample products, a handy tote, and
essentially the same print and promotional materials as included
in the larger kit version. To become a supervisor or qualify for
a higher level, distributors must achieve specified volumes of
product sales or earn certain amounts of royalty overrides
during specified time periods and
9
must re-qualify for the levels once each year. To attain
supervisor status, a distributor generally must be responsible
for sales of products representing at least 4,000 volume points
in one month or 2,500 volume points in two consecutive months.
China has its own unique marketing program. Volume points are
point values assigned to each of our products that are usually
equal in all countries and are based on the suggested retail
price of U.S. products (one volume point equates to one
U.S. dollar). Supervisors may then attain higher levels,
(consisting of the World Team, the Global Expansion Team, the
Millionaire Team, the Presidents Team, the Chairmans
Club and the Founders Circle) and earn increasing amounts of
royalty overrides based on sales in their downline organizations
and, for members of our Global Expansion Team and above, earn
production bonuses on sales in their downline organizations.
The following table sets forth the number of our sales leaders
and supervisor retention rates as of requalification period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At the end of February
|
|
|
|
Number of Sales Leaders
|
|
|
Supervisors Retention Rate
|
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
North America
|
|
|
41,252
|
|
|
|
45,766
|
|
|
|
54,314
|
|
|
|
38.6
|
%
|
|
|
41.2
|
%
|
|
|
43.1
|
%
|
Mexico & Central America
|
|
|
19,055
|
|
|
|
38,356
|
|
|
|
62,683
|
|
|
|
50.6
|
%
|
|
|
57.4
|
%
|
|
|
55.2
|
%
|
South America
|
|
|
28,240
|
|
|
|
40,111
|
|
|
|
51,302
|
|
|
|
33.4
|
%
|
|
|
32.4
|
%
|
|
|
32.9
|
%
|
EMEA
|
|
|
65,485
|
|
|
|
66,103
|
|
|
|
64,862
|
|
|
|
44.0
|
%
|
|
|
45.0
|
%
|
|
|
46.2
|
%
|
Asia Pacific (excluding China)
|
|
|
47,893
|
|
|
|
51,249
|
|
|
|
56,871
|
|
|
|
34.4
|
%
|
|
|
35.9
|
%
|
|
|
35.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Supervisors
|
|
|
201,925
|
|
|
|
241,585
|
|
|
|
290,032
|
|
|
|
39.7
|
%
|
|
|
41.5
|
%
|
|
|
42.5
|
%
|
China Sales Employees
|
|
|
|
|
|
|
1,987
|
|
|
|
8,759
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide Total Sales Leaders
|
|
|
201,925
|
|
|
|
243,572
|
|
|
|
298,791
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In February of each year, we remove from the rank of supervisor
those individuals who did not satisfy the supervisor
qualification requirements during the preceding twelve months.
Distributors who meet the supervisor requirements at any time
during the year are promoted to supervisor status at that time,
including any supervisors who were removed, but who subsequently
requalified. For the latest twelve month re-qualification period
ending January 2008, approximately 41.0% of our supervisors
re-qualified. Typically, distributors who purchase our product
for personal consumption or for short term weight loss or income
goals may stay with us for several months to one year while
supervisors who have committed time and effort to build a sales
organization generally stay for longer periods. We rely on
certifications from the selling distributors as to the amount
and source of product sales to other distributors which are not
directly verifiable by us. For supervisors to requalify and
retain their distributor organization and associated earnings,
they need to earn 4,000 volume points in one month or 2,500
volume points in each of two consecutive months. In order to
increase retailing of our products, we have modified our
requalification criteria to provide that any distributor that
earns at least 4,000 volume points in any
12-month
period can requalify as a supervisor and retain a discount of
50% from suggested retail prices, but will forfeit their
distributor organization and associated earnings.
Distributor
Earnings
Distributor earnings are derived from several sources. First,
distributors may earn profits by purchasing our products at
wholesale prices, which are discounted 25% to 50% from suggested
retail prices, depending on the distributors level within
our distributor network, and selling our products to retail
customers or to other distributors. Second, distributors who
sponsor other distributors and establish their own sales
organizations may earn (1) royalty overrides, up to 15% of
product retail sales in the aggregate, (2) production
bonuses, up to 7% of product retail sales in the aggregate and
(3) the Mark Hughes bonus, up to 1% of product retail sales
in the aggregate. Royalty overrides and bonuses together with
the distributor allowances represent the potential earnings to
distributors of up to approximately 73% of retail sales. Each
distributors success is dependent on two primary factors:
1) the time, effort and commitment a distributor puts into
his or her Herbalife business and 2) the product sales made
by a distributor and his or her sales organization.
10
Distributors, with the exception of China, earn the right to
receive royalty overrides upon attaining the level of supervisor
and above, and production bonuses upon attaining the level of
Global Expansion Team and above. Once a distributor becomes a
supervisor, he or she has an incentive to qualify, by earning
specified amounts of royalty overrides, as a member of the
Global Expansion Team, the Millionaire Team or the
Presidents Team, and thereby receive production bonuses of
up to 7%. We believe that the right of distributors to earn
royalty overrides and production bonuses contributes
significantly to our ability to retain our most productive
distributors.
Many of our non-supervisor distributors join Herbalife to obtain
a 25% discount on our products and become a discount consumer or
merely have a part-time income goal in mind. Consequently,
non-supervisor earnings tend to be relatively low and are not
tracked by the Company.
Under the regulations published by the Chinese Government,
direct selling companies are limited to the payment of gross
compensation to direct sellers of up to a maximum 30% of the
revenue they generate through their own sales of products to
consumers. We have incurred and will continue to incur
substantial ongoing additional costs relating to the inclusion
in the China business model of Company operated retail stores,
employed sales management personnel and Company provided
training and certification procedures for sales personnel,
features not common elsewhere in our traditional business model.
Distributor
Motivation and Training
We believe that motivation and training are key elements in
distributor success and that we and our distributor supervisors
have established a consistent schedule of events to support
these needs. We and our distributor leadership conduct thousands
of training sessions annually on local, regional and global
levels to educate and motivate our distributors. Every month,
there are hundreds of
one-day
Success Training Seminars held throughout the world. Annually,
in each major territory or region, there is a
three-day
World Team School that focuses on product and business
development and is typically attended by 2,000 to 10,000
distributors. Additionally, once a year in each region, we host
an Extravaganza at which our distributors from the region can
come to learn about new products, expand their skills and
celebrate their success. In 2007, such events were held in
Brazil, Colombia, the United States, Singapore, Germany and
Mexico. In addition to these training sessions, we have our own
Herbalife Broadcast Network that we use to provide
distributors continual training and the most current product and
marketing information. The Herbalife Broadcast Network can be
seen on the internet.
Distributor reward and recognition is a significant factor in
motivating our distributors. In 2007, we invested over
$64 million in regional and worldwide events and promotions
to motivate our distributors to achieve and exceed both sales
and recruiting goals. Examples of our worldwide promotions are
the 2007 Vacations and the Active World Team Promotion. The 2007
Vacations offer incentives for distributors to qualify to
receive a regional vacation. The Active World Team Promotion
provides cash and recognition incentives to distributors who
achieve all three requirements for becoming a World Team Member
and thus have proven themselves adept at building a
well-balanced business.
Geographic
Presence
As of December 31, 2007, we conducted business in 65
countries throughout the world. The following chart sets forth
the countries we currently operate in as of December 31,
2007, organized in the Companys five geographic regions,
and the year in which we commenced operations.
|
|
|
|
|
|
|
Year
|
|
Country
|
|
Entered
|
|
|
North America
|
|
|
|
|
USA
|
|
|
1980
|
|
Canada
|
|
|
1982
|
|
Jamaica
|
|
|
1999
|
|
Mexico and Central America
|
|
|
|
|
Mexico
|
|
|
1989
|
|
Dominican Republic
|
|
|
1994
|
|
11
|
|
|
|
|
|
|
Year
|
|
Country
|
|
Entered
|
|
|
Panama
|
|
|
2000
|
|
Costa Rica
|
|
|
2006
|
|
El Salvador
|
|
|
2007
|
|
South America
|
|
|
|
|
Venezuela
|
|
|
1994
|
|
Argentina
|
|
|
1994
|
|
Brazil
|
|
|
1995
|
|
Chile
|
|
|
1997
|
|
Colombia
|
|
|
2001
|
|
Bolivia
|
|
|
2004
|
|
Peru
|
|
|
2006
|
|
Asia Pacific
|
|
|
|
|
Australia
|
|
|
1983
|
|
New Zealand
|
|
|
1988
|
|
Japan
|
|
|
1989
|
|
Hong Kong
|
|
|
1992
|
|
Philippines
|
|
|
1994
|
|
Taiwan
|
|
|
1995
|
|
South Korea
|
|
|
1996
|
|
Thailand
|
|
|
1997
|
|
Indonesia
|
|
|
1998
|
|
India
|
|
|
1999
|
|
China
|
|
|
2001
|
|
Macau
|
|
|
2002
|
|
Singapore
|
|
|
2003
|
|
Malaysia
|
|
|
2006
|
|
EMEA
|
|
|
|
|
United Kingdom
|
|
|
1984
|
|
Spain
|
|
|
1989
|
|
Israel
|
|
|
1989
|
|
France
|
|
|
1990
|
|
Germany
|
|
|
1990
|
|
Portugal
|
|
|
1992
|
|
Czech Republic
|
|
|
1992
|
|
Italy
|
|
|
1992
|
|
Netherlands
|
|
|
1993
|
|
Belgium
|
|
|
1994
|
|
Poland
|
|
|
1994
|
|
Denmark
|
|
|
1994
|
|
Sweden
|
|
|
1994
|
|
Russia
|
|
|
1995
|
|
Austria
|
|
|
1995
|
|
Switzerland
|
|
|
1995
|
|
South Africa
|
|
|
1995
|
|
12
|
|
|
|
|
|
|
Year
|
|
Country
|
|
Entered
|
|
|
Norway
|
|
|
1995
|
|
Finland
|
|
|
1995
|
|
Greece
|
|
|
1996
|
|
Turkey
|
|
|
1998
|
|
Botswana
|
|
|
1998
|
|
Lesotho
|
|
|
1998
|
|
Namibia
|
|
|
1998
|
|
Swaziland
|
|
|
1998
|
|
Iceland
|
|
|
1999
|
|
Slovak Republic
|
|
|
1999
|
|
Cyprus
|
|
|
2000
|
|
Ireland
|
|
|
2000
|
|
Croatia
|
|
|
2001
|
|
Latvia
|
|
|
2002
|
|
Ukraine
|
|
|
2002
|
|
Estonia
|
|
|
2003
|
|
Lithuania
|
|
|
2003
|
|
Hungary
|
|
|
2005
|
|
Zambia
|
|
|
2007
|
|
In late 2007, we changed our geographic regions from seven to
five regions as part of our on-going Realignment for Growth
efforts. Historical information presented below relating to the
geographic regions has been reclassified to conform with current
geographic presentation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
Net Sales
|
|
|
Percent of
|
|
|
Countries
|
|
|
|
Year Ended December 31,
|
|
|
Total Net Sales
|
|
|
December 31,
|
|
Geographic Region
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
303.8
|
|
|
$
|
357.6
|
|
|
$
|
438.7
|
|
|
|
20.4
|
%
|
|
|
3
|
|
Mexico & Central America
|
|
|
219.9
|
|
|
|
376.9
|
|
|
|
384.6
|
|
|
|
17.9
|
%
|
|
|
5
|
|
South America
|
|
|
158.1
|
|
|
|
224.1
|
|
|
|
300.1
|
|
|
|
14.0
|
%
|
|
|
7
|
|
EMEA
|
|
|
545.3
|
|
|
|
548.0
|
|
|
|
567.7
|
|
|
|
26.5
|
%
|
|
|
36
|
|
Asia Pacific
|
|
|
339.7
|
|
|
|
378.9
|
|
|
|
454.7
|
|
|
|
21.2
|
%
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
$
|
1,566.8
|
|
|
$
|
1,885.5
|
|
|
$
|
2,145.8
|
|
|
|
100.0
|
%
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The top six countries have represented approximately 56%, 58.2%
and 56.1% of net sales in 2005, 2006, and 2007, respectively,
reflecting our broad geographical diversification.
After entering a new country, in many instances we experience an
initial period of rapid growth in sales as new distributors are
recruited, that is then followed by a decline in sales. We
believe that a significant factor affecting these markets is the
opening of other new markets within the same geographic region
or within the same or similar language or cultural bases. Some
distributors tend to focus their attention on the business
opportunities provided by these newer markets instead of
developing their established sales organizations in existing
markets. Additionally, in some instances, we have become aware
that certain sales in certain existing markets were attributable
to purchasers who distributed our products in countries that had
not yet been opened. When these countries were opened, the sales
in existing markets shifted to the newly opened markets,
resulting in a decline in sales in the existing markets. To the
extent we decide to open new markets in the future, we will
continue to seek to minimize the impact on distributor focus in
existing markets and to ensure that adequate distributor support
services and other Herbalife systems are in place to support
growth while maintaining prior sales levels within the region.
13
Manufacturing
and Distribution
All of our weight management, nutritional and personal care
products are manufactured for us by third party manufacturing
companies, with the exception of products distributed in and
sourced from China, where we have our own manufacturing
facility. However, we own proprietary formulations for
substantially all of our weight management products and dietary
and nutritional supplements. We source our products from
multiple manufacturers, with our top three suppliers accounting
for approximately 49.7% of our product purchases in 2007. In
addition, each of our products can be made available from a
secondary vendor if necessary. We work closely with our vendors
in an effort to achieve the highest quality standards and
product availability. We also have our own quality control lab
in which we routinely test products received from vendors. We
have established excellent relationships with our manufacturers
and continue to obtain improvements in supply services, product
quality and product delivery. Currently prices of some of our
key input materials such as soy, whey protein, fructose and
packaging material are increasing. However, we are confident we
can offset these increases with our cost reduction programs and
by raising the prices of our products.
In order to coordinate and manage the manufacturing of our
products, we utilize a significant demand planning and
forecasting process that is directly tied to our production
planning and purchasing systems. Using this sophisticated
planning software and process allows us to balance our inventory
levels to provide exceptional service to distributors while
minimizing working capital and inventory obsolescence.
Our global distribution system features centralized distribution
and telephone ordering systems coupled with storefront
distributor service centers. Our major distribution warehouses
have automated pick-to-light systems which
consistently deliver high order accuracy and inspection of every
shipment before it is sent to delivery. Shipping and processing
standards for orders placed are either the same day or the
following business day. We have central sales ordering
facilities for answering and processing telephone orders.
Operators at these centers are capable of conversing in multiple
languages.
Our products are distributed to foreign markets either from the
facilities of our manufacturers or from our Los Angeles or
Venray, Netherlands distribution centers. Products are
distributed in the United States market from our Los Angeles
distribution center, our Memphis distribution center or from our
sales centers in Dallas and Phoenix. Products distributed
globally are generally transported by truck, cargo ship or plane
to our international markets and are warehoused in either one of
our foreign distribution centers or a contracted third party
warehouse and distribution center. After the products arrive in
a foreign market, distributors purchase the products from the
local distribution center or the associated sales center. The
products manufactured in Europe are shipped to a centralized
warehouse facility, from which delivery by truck, ship or plane
to other international markets occurs.
Product
Return and Buy-Back Policies
In most markets, our products include a customer satisfaction
guarantee. Under this guarantee any customer who is not
satisfied with an Herbalife product for any reason may return it
or any unused portion of it within 30 days of purchase to
their distributor from whom it was purchased for a full refund
from the distributor or credit toward the purchase of another
Herbalife product. If they return the products to us on a timely
basis, the distributor may obtain replacement product from us
for such returned products. In addition, in most jurisdictions,
we maintain a buy-back program pursuant to which we will
repurchase products sold to a distributor provided that the
distributor resigns as an Herbalife distributor, returns the
product in marketable condition generally within twelve months
of original purchase and meets certain documentation and other
requirements. We believe this buy-back policy addresses a number
of the regulatory compliance issues pertaining to network
marketing, in that it offers monetary protection to distributors
who want to exit the business. Product returns, refunds and
buy-back expenses were approximately 1% of retail sales in each
of the years 2005, 2006 and 2007.
Management
Information, Internet and Telecommunication Systems
In order to facilitate our continued growth and support
distributor activities, we continually upgrade our management
information, internet and telecommunication systems. These
systems include: (1) a centralized host computer managed by
Hewlett Packard in Colorado, which is linked to our
international markets through a dedicated wide area network that
provides on-line, real-time computer connectivity and access and
hosts our legacy
14
operating systems and our new Oracle platform; (2) local
area networks of personal computers within our markets, serving
our regional administrative staffs; (3) an international
e-mail
system through which our employees communicate; (4) a
standardized Northern Telecom Meridian telecommunication system
in most of our markets; and (5) internet websites to
provide a variety of online services for distributors such as
status of qualifications, meeting announcements, product
information, application forms, educational materials and, in
the United States, sales ordering capabilities. These systems
are designed to provide, among other things, financial and
operating data for management, timely and accurate product
ordering, royalty override payment processing, inventory
management and detailed distributor records. We intend to
continue to invest in these systems in order to strengthen our
operating platform.
Regulation
General
In both our United States and foreign markets, we are affected
by extensive laws, governmental regulations, administrative
determinations, court decisions and similar constraints. Such
laws, regulations and other constraints exist at the federal,
state or local levels in the United States and at all levels of
government in foreign jurisdictions, including regulations
pertaining to: (1) the formulation, manufacturing,
packaging, labeling, distribution, importation, sale and storage
of our products; (2) product claims and advertising,
including direct claims and advertising by us, as well as claims
and advertising by distributors, for which we may be held
responsible; (3) our network marketing program;
(4) transfer pricing and similar regulations that affect
the level of U.S. and foreign taxable income and customs
duties; and (5) taxation of our independent distributors
(which in some instances may impose an obligation on us to
collect the taxes and maintain appropriate records).
Products
In the United States, the formulation, manufacturing, packaging,
storing, labeling, promotion, advertising, distribution and sale
of our products are subject to regulation by various
governmental agencies, including (1) the Food and Drug
Administration, or FDA, (2) the Federal Trade Commission,
or FTC, (3) the Consumer Product Safety Commission, or
CPSC, (4) the United States Department of Agriculture, or
USDA, (5) the Environmental Protection Agency, or EPA,
(6) the United States Postal Service, (7) United
States Customs and Border Protection, and (8) the Drug
Enforcement Administration. Our activities also are regulated by
various agencies of the states, localities and foreign countries
in which our products are manufactured, distributed and sold.
The FDA, in particular, regulates the formulation, manufacture
and labeling of over-the-counter, or OTC, drugs, conventional
foods, dietary supplements, and cosmetics such as those
distributed by us. FDA regulations require us and our suppliers
to meet relevant current good manufacturing practice, or cGMP,
regulations for the preparation, packing and storage of foods
and OTC drugs. On June 25, 2007, the FDA published its
final rule regulating cGMPs for dietary supplements. The final
rule became effective August 24, 2007 and large companies
such as Herbalife will have June 2008 to achieve compliance. We
expect to see an increase in certain manufacturing costs as a
result of the necessary increase in testing of raw ingredients
and finished products and compliance with higher quality
standards.
Most OTC drugs are subject to FDA Monographs that establish
labeling and composition for these products. Those of our
products which are classified as OTC must comply with these
Monographs, and our manufacturers must list all products with
the FDA and follow cGMP. Our cosmetic products are regulated for
safety by the FDA, which requires that ingredients meet industry
standards for non-allergenicity and non-toxicity. Performance
claims for cosmetics may not be therapeutic.
The U.S. 1994 Dietary Supplement Health and Education Act,
or DSHEA, revised the provisions of the Federal Food, Drug and
Cosmetic Act, or FFDCA, concerning the composition and labeling
of dietary supplements and, we believe, is generally favorable
to the dietary supplement industry. The legislation created a
new statutory class of dietary supplements. This new class
includes vitamins, minerals, herbs, amino acids and other
dietary substances for human use to supplement the diet, and the
legislation grandfathers, with some limitations, dietary
ingredients that were on the market before October 15,
1994. A dietary supplement that contains a dietary ingredient
that was not on the market before October 15, 1994 will
require evidence of a history of use or other evidence of safety
establishing that it is reasonably expected to be safe.
Manufacturers or marketers of dietary supplements in
15
the United States and certain other jurisdictions that make
product performance claims, including structure or function
claims, must have substantiation in their possession that the
statements are truthful and not misleading. The majority of the
products marketed by us in the United States are classified as
conventional foods or dietary supplements under the FFDCA.
Internationally, the majority of products marketed by us are
classified as foods or food supplements.
In January 2000, the FDA issued a regulation that defines the
types of statements that can be made concerning the effect of a
dietary supplement on the structure or function of the body
pursuant to DSHEA. Under DSHEA, dietary supplement labeling may
bear structure or function claims, which are claims that the
products affect the structure or function of the body, without
prior FDA approval, but with notification to the FDA. They may
not bear a claim that they can prevent, treat, cure, mitigate or
diagnose disease (a disease claim). The regulation describes how
the FDA distinguishes disease claims from structure or function
claims. During 2004, the FDA issued a guidance, paralleling an
earlier guidance from the FTC, defining a manufacturers
obligations to substantiate structure/function claims. The FDA
also issued a Structure/Function Claims Small Entity Compliance
Guide. In addition, the agency permits companies to use
FDA-approved full and qualified health claims for products
containing specific ingredients that meet stated requirements.
As a marketer of dietary and nutritional supplements and other
products that are ingested by consumers, we are subject to the
risk that one or more of the ingredients in our products may
become the subject of regulatory action. A number of states
restricted the sale of dietary supplements containing botanical
sources of ephedrine alkaloids. As a result of these state
regulations, we stopped sales of dietary supplements containing
botanical sources of ephedrine alkaloids due to a shift in
consumer preference for ephedra free products and a
significant increase in products liability insurance premiums
for products containing botanical sources of ephedrine group
alkaloids. On December 31, 2002, we ceased sales of
Thermojetics®
original green herbal tablets containing ephedrine alkaloids
derived from Chinese Ma huang, as well as
Thermojetics®
green herbal tablets and
Thermojetics®
gold herbal tablets (the latter two containing the herb Sida
cordifolia which is another botanical source of ephedrine
alkaloids). On February 6, 2004, the FDA published a rule
finding that dietary supplements containing ephedrine alkaloids
present an unreasonable risk of illness or injury under
conditions of use recommended or suggested in the labeling of
the product, or, if no conditions of use are suggested in the
labeling, under ordinary conditions of use, and are therefore
adulterated.
The FDA has on record a small number of reports of adverse
reactions allegedly resulting from the ingestion of our
Thermojetics®
original green tablet. These reports are among thousands of
reports of adverse reactions to these products sold by other
companies.
As a further outgrowth of the FDA ephedra safety review, the
FDA, in January 2004, announced that it would undertake a review
of the safety of the herb Citrus aurantium. We had
previously used Citrus aurantium in the
ShapeWorks®
Total
Control®
and
Thermojetics®
green ephedra-free dietary supplements sold in the United States
and in a number of international markets. Unconfirmed reports of
serious adverse events, reportedly associated with Citrus
aurantium, were disclosed by the FDA to the New York Times
during April 2004. Under the Freedom of Information Act, we
obtained a copy of those anecdotal serious adverse event
reports. No Herbalife dietary supplement containing Citrus
aurantium was cited by the FDA. Indeed, many cited products
from other companies did not even contain Citrus aurantium.
Nonetheless, we decided to reformulate our products and we
no longer market dietary supplements containing Citrus
aurantium anywhere in the world.
The FDAs decision to ban ephedra triggered a significant
reaction by the national media, some of whom are calling for the
repeal or amendment of DSHEA. These media view supposed
weaknesses within DSHEA as the underlying reason why
ephedra was allowed to remain on the market. We have been
advised that DSHEA opponents in Congress may use this anti-DSHEA
momentum to advance new legislation during the
110th Congress to amend or repeal DSHEA. If this should
occur we believe that the DSHEA opponents may propose the
following: (1) premarket approval for safety and
effectiveness of dietary ingredients; (2) specific
premarket review of dietary ingredient stimulants that are being
used to replace ephedra; (3) reversal of the burden of
proof standard which now rests on the FDA; and (4) a
redefining of dietary ingredient to remove either
botanicals or selected classes of ingredients now treated as
dietary ingredients.
On December 22, 2007, a new law went into effect in the
United States mandating the reporting of all serious adverse
events occurring within the United States which involve dietary
supplements or OTC drugs. We believe that
16
we are in full compliance with this new law having promulgated
and implemented a worldwide procedure governing adverse event
identification, investigation and reporting which is managed by
our Scientific Affairs department in collaboration with our
Medical Affairs department and our Distributor Relations Call
Centers. As a result of our receipt of adverse event reports, we
may from time to time elect, or be required, to remove a product
from a market, either temporarily or permanently.
On June 25, 2007, the FDA published its final rule
regulating current good manufacturing practices, or cGMP, for
dietary supplements. This final rule became effective on
August 24, 2007, and Herbalife will have until June, 2008
to achieve compliance. The final rule requires that companies
establish written procedures governing: (1) personnel,
(2) plant and equipment cleanliness, (3) lab and
testing, (4) packaging and labeling, and
(5) distribution. The FDA also required 100 percent
identity testing of all incoming raw materials, although an
interim final rule enables companies to petition for an
exemption from the 100 percent testing requirement if they
can demonstrate the existence of an appropriate statistical
sampling program. The new cGMPs will help ensure that dietary
supplements and dietary ingredients are not adulterated with
contaminants or impurities, and are labeled to accurately
reflect the active ingredients and other ingredients in the
products. We have evaluated the final cGMP rule with respect to
its potential impact upon the various contract manufacturers
that we use to manufacture our products, some of which might not
meet the new standards. It is important to note that the final
cGMP rule, in an effort to limit disruption, includes a
three-year phase-in for small businesses. This will mean that
some of our contract manufacturers will not be fully impacted by
the proposed regulation until at least 2010. However, the final
cGMP rule can be expected to result in additional costs and
possibly the need to seek alternate suppliers. See
Item 1A Risk Factors for further discussion
regarding the recently promulgated cGMP regulations.
Some of the products marketed by us are considered conventional
foods and are currently labeled as such. Within the United
States, this category of products is subject to the Nutrition,
Labeling and Education Act, or NLEA, and regulations promulgated
under the NLEA. The NLEA regulates health claims, ingredient
labeling and nutrient content claims characterizing the level of
a nutrient in the product. The ingredients added to conventional
foods must either be generally recognized as safe by experts, or
GRAS, or be approved as food additives under FDA regulations.
In foreign markets, prior to commencing operations and prior to
making or permitting sales of our products in the market, we may
be required to obtain an approval, license or certification from
the relevant countrys ministry of health or comparable
agency. Where a formal approval, license or certification is not
required, we nonetheless seek a favorable opinion of counsel
regarding our compliance with applicable laws. Prior to entering
a new market in which a formal approval, license or certificate
is required, we work extensively with local authorities in order
to obtain the requisite approvals. The approval process
generally requires us to present each product and product
ingredient to appropriate regulators and, in some instances,
arrange for testing of products by local technicians for
ingredient analysis. The approvals may be conditioned on
reformulation of our products, or may be unavailable with
respect to some products or some ingredients. Product
reformulation or the inability to introduce some products or
ingredients into a particular market may have an adverse effect
on sales. We must also comply with product labeling and
packaging regulations that vary from country to country. Our
failure to comply with these regulations can result in a product
being removed from sale in a particular market, either
temporarily or permanently.
In 2005, Herbalife voluntarily elected to temporarily withdraw
its Sesame & Herb tablet product from the Israeli
market. This product, which has been on the market since 1989,
was sold only in Israel. Herbalifes voluntary decision to
temporarily withdraw this product accompanied the initiation of
a review by the Israeli Ministry of Health of anecdotal case
reports of individuals having varying liver conditions when it
was reported that a small number of these individuals had
consumed Herbalife products. Herbalife scientists and medical
doctors have closely cooperated with the Ministry of Health to
facilitate this review. This review is ongoing and there can be
no assurances as to the outcome.
The FTC, which exercises jurisdiction over the advertising of
all of our products, has in the past several years instituted
enforcement actions against several dietary supplement companies
and against manufacturers of weight loss products generally for
false and misleading advertising of some of their products.
These enforcement actions have often resulted in consent decrees
and monetary payments by the companies involved. In addition,
the FTC has increased its scrutiny of the use of testimonials,
which we also utilize, as well as the role of expert endorsers
and
17
product clinical studies. Although we have not been the target
of FTC enforcement action for the advertising of our products,
we cannot be sure that the FTC, or comparable foreign agencies,
will not question our advertising or other operations in the
future. It is unclear whether the FTC will subject our
advertisements to increased surveillance to ensure compliance
with the principles set forth in its published advertising
guidance.
In Europe, an EU Health Claim regulation was recently finalized.
The final regulation will have an adverse effect on existing
product wellness, well-being and
good for you claims presently made on existing
product labeling, literature and advertising. Herbalife is
currently assembling the necessary scientific substantiation for
its European product claims based on the requirements of this
recently enacted regulation.
In some countries, regulations applicable to the activities of
our distributors also may affect our business because in some
countries we are, or regulators may assert that we are,
responsible for our distributors conduct. In these
countries, regulators may request or require that we take steps
to ensure that our distributors comply with local regulations.
The types of regulated conduct include: (1) representations
concerning our products; (2) income representations made by
us and/or
distributors; (3) public media advertisements, which in
foreign markets may require prior approval by regulators; and
(4) sales of products in markets in which the products have
not been approved, licensed or certified for sale.
In some markets, it is possible that improper product claims by
distributors could result in our products being reviewed by
regulatory authorities and, as a result, being classified or
placed into another category as to which stricter regulations
are applicable. In addition, we might be required to make
labeling changes.
We are unable to predict the nature of any future laws,
regulations, interpretations or applications, nor can we predict
what effect additional governmental regulations or
administrative orders, when and if promulgated, would have on
our business in the future. They could, however, require:
(1) the reformulation of some products not capable of being
reformulated; (2) imposition of additional record keeping
requirements; (3) expanded documentation of the properties
of some products; (4) expanded or different labeling;
(5) additional scientific substantiation regarding product
ingredients, safety or usefulness;
and/or
(6) additional distributor compliance surveillance and
enforcement action by us.
Any or all of these requirements could have a material adverse
effect on our results of operations and financial condition. All
of our officers and directors are subject to a permanent
injunction issued in October 1986 pursuant to the settlement of
an action instituted by the California Attorney General, the
State Health Director and the Santa Cruz County District
Attorney. We consented to the entry of this injunction without
in any way admitting the allegations of the complaint. The
injunction prevents us and our officers and directors from
making specified claims in future advertising of our products
and required us to implement some documentation systems with
respect to payments to our distributors. At the same time, the
injunction does not prevent us from continuing to make specified
claims concerning our products that have been made and are being
made, provided that we have a reasonable basis for making the
claims.
We are aware that, in some of our international markets, there
has been recent adverse publicity concerning products that
contain ingredients that have been genetically modified, or GM.
In some markets, the possibility of health risks or perceived
consumer preference thought to be associated with GM ingredients
has prompted proposed or actual governmental regulation. For
example, the European Union has adopted a EC
Regulation 1829/2003 affecting the labeling of products
containing ingredients that have been genetically modified, and
the documents manufacturers and marketers will need to possess
to ensure traceability at all steps in the chain of
production and distribution. This new regulation, which took
effect in 2004, has been implemented by us and our contract
manufacturers, resulting in modifications to our labeling, and
in some instances, to some of our foods and food supplements
sold in Europe. Differing GM regulations affecting us also have
been adopted in Brazil, Japan, Korea, Taiwan and Thailand. We
cannot anticipate the extent to which future regulations in our
markets will restrict the use of GM ingredients in our products
or the impact of any regulations on our business in those
markets. In response to any applicable regulations, we would,
where practicable, attempt to reformulate our products to
satisfy the regulations. We believe, based upon currently
available information, that compliance with regulatory
requirements in this area should not have a material adverse
effect on us or our business. However, because publicity and
governmental scrutiny of GM ingredients is a relatively new and
evolving area, there can be no assurance in this regard. If a
significant number of our products were found to be genetically
modified and regulations in our markets
18
significantly restricted the use of GM ingredients in our
products, our business could be materially adversely affected.
We have been required to comply with recent regulations within
the European Union, Australia, Brazil, Canada, China, Hong Kong,
Japan, Taiwan, and Thailand affecting the use
and/or
labeling of irradiated raw ingredients.
Compliance with GM, BSE and irradiation regulations can be
expected to increase the cost of manufacturing certain of our
products.
Network
Marketing Program
Our network marketing program is subject to a number of federal
and state regulations administered by the FTC and various state
agencies as well as regulations in foreign markets administered
by foreign agencies. Regulations applicable to network marketing
organizations generally are directed at ensuring that product
sales ultimately are made to consumers and that advancement
within our organization is based on sales of the
organizations products rather than investments in the
organization or other non-retail sales related criteria. For
instance, in some markets, there are limits on the extent to
which distributors may earn royalty overrides on sales generated
by distributors that were not directly sponsored by the
distributor. When required by law, we obtain regulatory approval
of our network marketing program or, when this approval is not
required, the favorable opinion of local counsel as to
regulatory compliance. Nevertheless, we remain subject to the
risk that, in one or more markets, our marketing system could be
found not to be in compliance with applicable regulations.
Failure by us to comply with these regulations could have a
material adverse effect on our business in a particular market
or in general.
On April 12, 2006, the FTC, issued a notice of proposed
rulemaking which, if implemented, will regulate all sellers of
business opportunities in the United States. The
proposed rule would, among other things, require all sellers of
business opportunities, which would likely include Herbalife, to
(i) implement a seven day waiting period before entering
into an agreement with a prospective business opportunity
purchaser, and (ii) provide all prospective business
opportunity purchasers with substantial information in writing
at the beginning of the waiting period regarding the business
opportunity, including information relating to: representations
made as to the earnings experience of other business opportunity
purchasers, the names and telephone numbers of recent purchasers
in their geographic area, cancellation or refund policies and
requests within the prior two years, certain legal actions
against the company, its affiliated companies and company
officers, directors, sales managers and certain others. We,
other direct selling companies, the Direct Selling Association,
or the DSA, and other interested parties have filed over 17,000
comments with the FTC that are publicly available regarding the
proposed rule through the FTCs website at
http://www.ftc.gov/os/comments/businessopprule/index.htm.
We, the DSA, other direct selling companies, and other
interested parties also filed rebuttal comments with
the FTC in September, 2006. Based on information currently
available, we anticipate that the final rule may require several
years to become final and effective, and may differ
substantially from the rule as originally proposed. Nevertheless
the proposed rule, if implemented in its original form, would
negatively impact our U.S. business.
We also are subject to the risk of private party challenges to
the legality of our network marketing program. For example, in
Webster v. Omnitrition International, Inc., 79 F.3d
776 (9th Cir. 1996), the multi-level marketing program of
Omnitrition International, Inc., or Omnitrition, was
successfully challenged in a class action by Omnitrition
distributors who alleged that Omnitrition was operating an
illegal pyramid scheme in violation of federal and
state laws. We believe that our network marketing program
satisfies the standards set forth in the Omnitrition case and
other applicable statutes and case law defining a legal
marketing system, in part based upon significant differences
between our marketing system and that described in the
Omnitrition case.
Herbalife International and certain of its independent
distributors have been named as defendants in a purported class
action lawsuit filed February 17, 2005, in the Superior
Court of California, County of San Francisco, and served on
Herbalife International on March 14, 2005
(Minton v. Herbalife International, et al). The case
has been transferred to the Los Angeles County Superior Court.
The plaintiff is challenging the marketing practices of certain
Herbalife International independent distributors and Herbalife
International under various state laws prohibiting endless
chain schemes, insufficient disclosure in assisted
marketing plans, unfair and deceptive
19
business practices, and fraud and deceit. The plaintiff alleges
that the Freedom Group system operated by certain independent
distributors of Herbalife International products places too much
emphasis on recruiting and encourages excessively large
purchases of product and promotional materials by distributors.
The plaintiff also alleges that Freedom Group pressured
distributors to disseminate misleading promotional materials.
The plaintiff seeks to hold Herbalife International vicariously
liable for the actions of its independent distributors and is
seeking damages and injunctive relief. On January 24, 2007,
the Superior Court denied class certification of all claims,
except for the claim under California law prohibiting
endless chain schemes. That claim was granted
California-only class certification, provided that class counsel
is able to substitute in as a plaintiff a California resident
with claims typical of the class. We believe that we have
meritorious defenses to the suit.
Herbalife International and certain of its distributors were
defendants in a class action lawsuit filed July 16, 2003,
in the Circuit Court of Ohio County in the State of West
Virginia (Mey v. Herbalife International, Inc., et
al). The complaint alleged that certain telemarketing
practices of certain Herbalife International distributors
violated the Telephone Consumer Protection Act, or TCPA, and
sought to hold Herbalife International vicariously liable for
the practices of its independent distributors. More
specifically, the plaintiffs complaint alleged that
several of Herbalife Internationals distributors used
pre-recorded telephone messages and faxes to contact prospective
customers in violation of the TCPAs prohibition of such
practices. Without in any way acknowledging liability or
wrongdoing by us or our independent distributors, we and the
other defendants have reached a binding settlement with the
plaintiffs. Under the terms of the settlement the defendants
collectively paid $7 million into a fund to be distributed
to qualifying class members. The relevant amount paid by us was
previously fully reserved in our financial statements. The
settlement has received the final approval of the Court in
January 2008.
We are also subject to the risk of private party challenges to
the legality of our network marketing program. The multi-level
marketing programs of other companies have been successfully
challenged in the past, and in a current lawsuit, allegations
have been made challenging the legality of our network marketing
program in Belgium. Test Ankoop-Test Achat, a Belgian consumer
protection organization, sued Herbalife International Belgium,
S.V., or HIB, on August 26, 2004, alleging that HIB
violated Article 84 of the Belgian Fair Trade Practices Act
by engaging in pyramid selling, i.e., establishing a
network of professional or non-professional sales people who
hope to make a profit more through the expansion of that network
rather than through the sale of products to end-consumers. The
plaintiff is seeking a payment of 25,000 (equal to
approximately $36,500 as of December 31, 2007) per
purported violation as well as costs of the trial. For the year
ended December 31, 2007, our net sales in Belgium were
approximately $16.0 million. Currently, the lawsuit is in
the pleading stage. The plaintiffs filed their initial brief on
September 27, 2005. We filed a reply brief on May 9,
2006. There is no date yet for the oral hearings. An adverse
judicial determination with respect to our network marketing
program, or in proceedings not involving us directly but which
challenge the legality of multi-level marketing systems, in
Belgium or in any other market in which we operate, could
negatively impact our business.
It is an ongoing part of our business to monitor and respond to
regulatory and legal developments, including those that may
affect our network marketing program. However, the regulatory
requirements concerning network marketing programs do not
include bright line rules and are inherently fact-based. An
adverse judicial determination with respect to our network
marketing program could have a material adverse effect on our
business. An adverse determination could: (1) require us to
make modifications to our network marketing program,
(2) result in negative publicity or (3) have a
negative impact on distributor morale. In addition, adverse
rulings by courts in any proceedings challenging the legality of
multi-level marketing systems, even in those not involving us
directly, could have a material adverse effect on our operations.
Transfer
Pricing and Similar Regulations
In many countries, including the United States, we are subject
to transfer pricing and other tax regulations designed to ensure
that appropriate levels of income are reported as earned by our
U.S. or local entities and are taxed accordingly. In
addition, our operations are subject to regulations designed to
ensure that appropriate levels of customs duties are assessed on
the importation of our products.
Although we believe that we are in substantial compliance with
all applicable regulations and restrictions, we are subject to
the risk that governmental authorities could audit our transfer
pricing and related practices and assert
20
that additional taxes are owed. For example, we are currently
subject to pending or proposed audits that are at various levels
of review, assessment or appeal in a number of jurisdictions
involving transfer pricing issues, income taxes, duties, value
added taxes, withholding taxes and related interest and
penalties in material amounts. In some circumstances, additional
taxes, interest and penalties have been assessed, and we will be
required to appeal or litigate to reverse the assessments. We
have taken advice from our tax advisors and believe that there
are substantial defenses to the allegations that additional
taxes are owed, and we are vigorously defending against the
imposition of additional proposed taxes. The ultimate resolution
of these matters may take several years, and the outcome is
uncertain.
In the event that the audits or assessments are concluded
adversely to us, we may or may not be able to offset or mitigate
the consolidated effect of foreign income tax assessments
through the use of U.S. foreign tax credits. Currently, we
anticipate utilizing the majority of our foreign tax credits in
the year in which they arise with the unused amount carried
forward. Because the laws and regulations governing
U.S. foreign tax credits are complex and subject to
periodic legislative amendment, we cannot be sure that we would
in fact be able to take advantage of any foreign tax credits in
the future. As a result, adverse outcomes in these matters could
have a material impact on our financial condition and operating
results.
Other
Regulations
We also are subject to a variety of other regulations in various
foreign markets, including regulations pertaining to social
security assessments, employment and severance pay requirements,
import/export regulations and antitrust issues. As an example,
in many markets, we are substantially restricted in the amount
and types of rules and termination criteria that we can impose
on distributors without having to pay social security
assessments on behalf of the distributors and without incurring
severance obligations to terminated distributors. In some
countries, we may be subject to these obligations in any event.
Our failure to comply with these regulations could have a
material adverse effect on our business in a particular market
or in general. Assertions that we failed to comply with
regulations or the effect of adverse regulations in one market
could adversely affect us in other markets as well by causing
increased regulatory scrutiny in those other markets or as a
result of the negative publicity generated in those other
markets.
Compliance
Procedures
As indicated above, Herbalife, our products and our network
marketing program are subject, both directly and indirectly
through distributors conduct, to numerous federal, state
and local regulations, both in the United States and foreign
markets. Beginning in 1985, we began to institute formal
regulatory compliance measures by developing a system to
identify specific complaints against distributors and to remedy
any violations of Herbalifes rules by distributors through
appropriate sanctions, including warnings, suspensions and, when
necessary, terminations. In our manuals, seminars and other
training programs and materials, we emphasize that distributors
are prohibited from making therapeutic claims for our products.
Our general policy regarding acceptance of distributor
applications from individuals who do not reside in one of our
markets is to refuse to accept the individuals distributor
application. From time to time, exceptions to the policy are
made on a
country-by-country
basis.
In order to comply with regulations that apply to both us and
our distributors, we conduct considerable research into the
applicable regulatory framework prior to entering any new market
to identify all necessary licenses and approvals and applicable
limitations on our operations in that market. Typically, we
conduct this research with the assistance of local legal counsel
and other representatives. We devote substantial resources to
obtaining the necessary licenses and approvals and bringing our
operations into compliance with the applicable limitations. We
also research laws applicable to distributor operations and
revise or alter our distributor manuals and other training
materials and programs to provide distributors with guidelines
for operating a business, marketing and distributing our
products and similar matters, as required by applicable
regulations in each market. We, however, are unable to monitor
our supervisors and distributors effectively to ensure that they
refrain from distributing our products in countries where we
have not commenced operations, and we do not devote significant
resources to this type of monitoring.
21
In addition, regulations in existing and new markets often are
ambiguous and subject to considerable interpretive and
enforcement discretion by the responsible regulators. Moreover,
even when we believe that we and our distributors are initially
in compliance with all applicable regulations, new regulations
regularly are being added and the interpretation of existing
regulations is subject to change. Further, the content and
impact of regulations to which we are subject may be influenced
by public attention directed at us, our products or our network
marketing program, so that extensive adverse publicity about us,
our products or our network marketing program may result in
increased regulatory scrutiny.
It is an ongoing part of our business to anticipate and respond
to new and changing regulations and to make corresponding
changes in our operations to the extent practicable. Although we
devote considerable resources to maintaining our compliance with
regulatory constraints in each of our markets, we cannot be sure
that (1) we would be found to be in full compliance with
applicable regulations in all of our markets at any given time
or (2) the regulatory authorities in one or more markets
will not assert, either retroactively or prospectively or both,
that our operations are not in full compliance. These assertions
or the effect of adverse regulations in one market could
negatively affect us in other markets as well by causing
increased regulatory scrutiny in those other markets or as a
result of the negative publicity generated in those other
markets. These assertions could have a material adverse effect
on us in a particular market or in general. Furthermore,
depending upon the severity of regulatory changes in a
particular market and the changes in our operations that would
be necessitated to maintain compliance, these changes could
result in our experiencing a material reduction in sales in the
market or determining to exit the market altogether. In this
event, we would attempt to devote the resources previously
devoted to the market, to a new market or markets or other
existing markets. However, we cannot be sure that this
transition would not have an adverse effect on our business and
results of operations either in the short or long-term.
Trademarks
and Proprietary Formulas
We use the umbrella trademarks Herbalife and the Tri-Leaf design
worldwide, and protect several other trademarks and trade names
related to our products and operations, such as
Shapeworks®,
Nourifusion®,
and
Liftoff®.
Our trademark registrations are issued through the United States
Patent and Trademark Office and comparable agencies in the
foreign countries. We consider our trademarks and trade names to
be an important factor in our business. We also take care in
protecting the intellectual property rights of our proprietary
formulas by restricting access to our formulas within the
Company to those persons or departments that require access to
them to perform their functions, and by requiring our finished
goods-suppliers and consultants to execute supply and
non-disclosure agreements that seek to contractually protect our
intellectual property rights. Disclosure of these formulas, in
redacted form, is also necessary to obtain sanitary
registrations in many countries. We also make efforts to protect
some unique formulations under patent law. For example, we have
sought through our employee inventors one or more patents in the
United States and certain other markets to protect the
formulation of the
Liftoff®
brand effervescent supplement. The United States Patent
Office has recently granted patent no. 7,329,419 to our
employee inventors for the composition that constitutes the
current U.S. Total
Control®
product formula. All rights in this patent have been
assigned to Herbalife. We strive to protect all new product
developments as the confidential trade secrets of the Company
and its inventor employees. However, despite our efforts, we may
be unable to prevent third parties from infringing upon or
misappropriating our proprietary rights.
Competition
The business of marketing weight management and nutrition
products is highly competitive. This market segment includes
numerous manufacturers, distributors, marketers, retailers and
physicians that actively compete for the business of consumers
both in the United States and abroad. The market is highly
sensitive to the introduction of new products or weight
management plans, including various prescription and over the
counter drugs that may rapidly capture a significant share of
the market. As a result, our ability to remain competitive
depends in part upon the successful introduction of new
products. In addition, we anticipate that we will be subject to
increasing competition in the future from sellers that utilize
electronic commerce. We cannot be sure of the impact of
electronic commerce or that it will not adversely affect our
business.
We are subject to significant competition for the recruitment of
distributors from other network marketing organizations,
including those that market weight management products,
nutritional supplements and personal care
22
products, as well as other types of products. Some of our
competitors are substantially larger than we are, and have
considerably greater financial resources than we have. Our
ability to remain competitive depends, in significant part, on
our success in recruiting and retaining distributors through an
attractive compensation plan and other incentives. We believe
that our production bonus program, international sponsorship
program and other compensation and incentive programs provide
our distributors with significant earning potential. However, we
cannot be sure that our programs for recruitment and retention
of distributors will be successful.
Executive
Officers of the Registrant
The table sets forth certain information, as of
December 31, 2007, regarding each person who serves as an
executive officer of the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Officer
|
Name
|
|
Age
|
|
Position with the Company
|
|
Since
|
|
Michael O. Johnson
|
|
|
53
|
|
|
Chief Executive Officer, Director, Chairman of the Board
|
|
|
2003
|
|
Gregory Probert
|
|
|
51
|
|
|
President, Chief Operating Officer
|
|
|
2003
|
|
Richard Goudis
|
|
|
46
|
|
|
Chief Financial Officer
|
|
|
2004
|
|
Brett R. Chapman
|
|
|
52
|
|
|
General Counsel and Corporate Secretary
|
|
|
2003
|
|
Steve Henig Ph.D.
|
|
|
65
|
|
|
Chief Scientific Officer
|
|
|
2005
|
|
Michael O. Johnson is Chairman and Chief Executive
Officer of the Company. Mr. Johnson joined the Company in
April 2003 after 17 years with The Walt Disney Company,
where he most recently served as President of Walt Disney
International, and also served as President of Asia Pacific for
The Walt Disney Company and President of Buena Vista Home
Entertainment. Mr. Johnson has also previously served as a
publisher of Audio Times magazine, and has directed the
regional sales efforts of Warner Amex Satellite Entertainment
Company for three of its television channels, including MTV,
Nickelodeon and The Movie Channel. Mr. Johnson formerly
served as a director of Univision Communications, Inc., a
television company serving Spanish-speaking Americans and
currently serves on the board of Loyola High School of Los
Angeles. Mr. Johnson received his Bachelor of Arts in
Political Science from Western State College.
Gregory Probert is President and Chief Operating Officer
of the Company. Mr. Probert joined the Company in August
2003, after serving as President and CEO of DMX MUSIC for over
2 years. Mr. Probert joined DMX MUSIC after serving as
Chief Operating Officer of planet Lingo, where he led the team
that designed and built the companys first product, an
online conversational system for the $20 billion ESL market
in Japan. Immediately prior to planet Lingo, Mr. Probert
spent 12 years with The Walt Disney Company, where he most
recently served as Executive Vice President for the
$3.5 billion Buena Vista Home Entertainment worldwide
business. Mr. Proberts positions with The Walt Disney
Company also included service as Executive Vice President of the
International Home Video Division, Senior Vice President and
Managing Director of Buena Vista Home Entertainment, Asia
Pacific Region, based in Hong Kong, and Vice President Financial
of Buena Vista International, Disneys theatrical
distribution arm, among others. Mr. Probert received his
Bachelor of Arts from the University of Southern California.
Richard Goudis is Chief Financial Officer of the Company.
Mr. Goudis joined the Company in June 2004 after serving as
the Chief Operating Officer of Rexall Sundown, a Nasdaq
100 company that was sold to Royal Numico in 2000, from
1998 to 2001. After the sale to Royal Numico, Mr. Goudis
had operations responsibility for all of Royal Numicos
U.S. investments, including General Nutrition Centers, or
GNC, Unicity International and Rexall Sundown. From 2002 to
May 2004, Mr. Goudis was a partner at Flamingo Capital
Partners, a firm he founded with several retired executives from
Rexall Sundown. Prior to working at Rexall Sundown,
Mr. Goudis worked at Sunbeam Corporation and
Pratt & Whitney. Mr. Goudis graduated from the
University of Massachusetts with a degree in Accounting and he
received his MBA from Nova Southeastern University.
Brett R. Chapman is General Counsel and Secretary of the
Company. Mr. Chapman joined the Company in October 2003
after spending thirteen years at The Walt Disney Company, most
recently as its Senior Vice President and Deputy General
Counsel, with responsibility for all legal matters relating to
Disneys Media Networks Group,
23
including the ABC Television Network, the companys cable
properties including The Disney Channel and ESPN, and
Disneys radio and internet businesses. Prior to working at
The Walt Disney Company, Mr. Chapman was an associate at
the law firm of Skadden, Arps, Slate, Meagher & Flom
LLP. Mr. Chapman received his Bachelor of Science and
Master of Science in Business Administration from California
State University, Northridge and his Juris Doctorate from
Southwestern University School of Law.
Steve Henig, Ph.D. is Chief Scientific Officer of
the Company. Mr. Henig joined the Company in July 2005
after spending 6 years at Ocean Spray Cranberries, Inc., as
Senior Vice President, technology and innovation with
responsibility for the companys new products program and
medical research program. Prior to working at Ocean Spray
Cranberries, Inc. Mr. Henig served as Senior Vice
President, technology and marketing services at Con Agras
Grocery products. Mr. Henig holds a Ph.D. in food science
from Rutgers University, a M.S. in food and biotechnology and a
B.S. in chemical engineering from Technion-Israel Institute of
Technology.
Employees
As of December 31, 2007, we had approximately
3,600 employees. In China, as of December 31, 2007, we
also had labor contracts with approximately 22,000 employed
sales representatives. These numbers do not include our
distributors, who are independent contractors rather than
employees. Except for some employees in Mexico and in certain
European countries, none of our employees are members of any
labor union, and we have never experienced any business
interruption as a result of any labor disputes.
Available
Information
Our internet website address is www.Herbalife.com. We
make available free of charge on our website our Annual Reports
on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Current Reports on
Form 8-K
and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended, or the Exchange Act, as soon as reasonably
practical after we file such material with, or furnish it to,
the Securities and Exchange Commission, or SEC. This information
is also available in print to any shareholder who request it,
with any such requests addressed to Investor Relations, 1800
Century Park East, Los Angeles, CA 90067. Certain of these
documents may also be obtained by calling the SEC at
1-800-SEC-0330.
The SEC also maintains an Internet website that contains
reports, and other information regarding issuers that file
electronically with the SEC at www.sec.gov. We also make
available free of charge on our website our Corporate Governance
Guidelines, our Code of Business Conduct and Ethics, and the
Charters of our Audit Committee, Corporate Governance and
Nominating Committee, and Compensation Committee.
24
PART III.
|
|
Item 10.
|
DIRECTORS
AND EXECUTIVE OFFICERS OF THE REGISTRANT
|
The information required under this Item is incorporated herein
by reference to our definitive proxy statement to be filed with
the SEC no later than 120 days after the close of our
fiscal year ended December 31, 2007, except that the
information required with respect to our executive officers is
set forth under Item 1 Business, of this
Amendment, and is incorporated herein by reference.
PART IV
|
|
Item 15.
|
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
31
|
.1
|
|
Rule 13a-14(a)
Certification of Chief Executive Officer
|
|
*
|
|
31
|
.2
|
|
Rule 13a-14(a)
Certification of Chief Financial Officer
|
|
*
|
|
32
|
.1
|
|
Section 1350 Certification of Chief Executive Officer
|
|
*
|
|
32
|
.2
|
|
Section 1350 Certification of Chief Financial Officer
|
|
*
|
25
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereto duly authorized.
HERBALIFE Ltd.
Richard Goudis
Chief Financial Officer
Dated: April 30, 2008
26